136 related articles for article (PubMed ID: 6327967)
1. Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids.
Galligan JJ; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Jun; 229(3):641-8. PubMed ID: 6327967
[TBL] [Abstract][Full Text] [Related]
2. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
3. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
[TBL] [Abstract][Full Text] [Related]
4. Opioid profiles of Cys2-containing enkephalin analogues.
Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
7. A novel phencyclidine analog interacts selectively with mu opioid receptors.
Itzhak Y; Simon EJ
J Pharmacol Exp Ther; 1984 Aug; 230(2):383-6. PubMed ID: 6086884
[TBL] [Abstract][Full Text] [Related]
8. Subsensitivity to opioids is receptor-specific in isolated guinea pig ileum and mouse vas deferens after obstructive cholestasis.
Dehpour AR; Rastegar H; Jorjani M; Roushanzamir F; Joharchi K; Ahmadiani A
J Pharmacol Exp Ther; 2000 Jun; 293(3):946-51. PubMed ID: 10869396
[TBL] [Abstract][Full Text] [Related]
9. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
[TBL] [Abstract][Full Text] [Related]
10. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
[TBL] [Abstract][Full Text] [Related]
11. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
12. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
Sánchez-Blázquez P; García-España A; Garzón J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
14. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat.
Galligan JJ; Burks TF
J Pharmacol Exp Ther; 1983 Aug; 226(2):356-61. PubMed ID: 6875849
[TBL] [Abstract][Full Text] [Related]
15. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
16. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
Bell KM; Traynor JR
Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
[TBL] [Abstract][Full Text] [Related]
17. Changes in opioid receptor selectivity following processing of peptide E: effect on gut motility.
Davis TP; Gillespie TJ; Shook J; Kramer TH; Hoyer G; Hawkins K; Davis P; Yamamura HI; Burks TF
Gastroenterology; 1991 Jun; 100(6):1603-15. PubMed ID: 1850373
[TBL] [Abstract][Full Text] [Related]
18. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
Gyires K; Rónai AZ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
[TBL] [Abstract][Full Text] [Related]
19. In vitro study of the interaction of salmon calcitonin with mu, delta and kappa opioid agonists.
Martín MI; Alfaro MJ; Goicoechea C; Colado MI
Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):324-8. PubMed ID: 8386807
[TBL] [Abstract][Full Text] [Related]
20. Central effect of mu-opioid agonists on antral motility in conscious rats.
Tsuchida D; Fukuda H; Koda K; Miyazaki M; Pappas TN; Takahashi T
Brain Res; 2004 Oct; 1024(1-2):244-50. PubMed ID: 15451387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
